Friday, Apr 18 2025 | Time 17:33 Hrs(IST)
Business Economy


OneSource secured approval from Brazil for its flagship facility in Bengaluru

Hyderabad, Apr 10 (UNI) OneSource Specialty Pharma Limited (formerly known as Stelis Biopharma Limited), India’s first specialty pharma pure-play CDMO business, on Thursday announced that its flagship Unit 2 facility in Bengaluru has been granted Good Manufacturing Practices (GMP) certification by ANVISA, the Brazilian Health Regulatory Agency, following a successful regulatory inspection held in November last year.
Unit 2 is OneSource’s flagship site dedicated to manufacturing high quality Biologics drug substance and finished products including Drug Device Combinations (DDC) and other injectable products, the pharma company said in a release.
Neeraj Sharma, CEO & Managing Director of OneSource, said, “This approval now enables OneSource to supply pharmaceutical products specially DDCs, including GLP-1s manufactured at this site to the Brazilian market upon our customers getting their product approvals. It is a critical milestone for our company as Brazil is one of the biggest markets opening for generic Semaglutide in 2026.”
The pharma company operates five state-of-the-art facilities in India, all approved by major regulatory bodies, including the USFDA and EU authorities.
UNI KNR SS
More News

Zydus Medtech partners with Braile Biomedica to commercialise TAVI technology

18 Apr 2025 | 3:16 PM

Mumbai, Apr 18 (UNI) Zydus MedTech Private Limited, a wholly owned subsidiary of Zydus Lifesciences Limited on Friday entered into a strategic partnership with Braile Biomédica Indústria, Comércio e Representações Ltda., (Braile Biomedica) - an innovative cardiovascular device manufacturer based in Brazil - to exclusively commercialise its Transcatheter Aortic Valve Implantation (TAVI) technology across Europe, India, and other select markets.

see more..

HDFC Securities posts robust financials

18 Apr 2025 | 2:59 PM

Kolkata, Apr 18 (UNI) HDFC Securities Limited reported exceptional performance for the financial year that ended on March 31, 2025, achieving a total income of Rs 3,265 crore, a robust 23 per cent increase from Rs 2,661 crore in the previous financial year.

see more..

Hyd: GHIAL operated Rajiv Gandhi International Airport Achieves Prestigious ACA Level 5 Carbon Accreditation

18 Apr 2025 | 1:41 PM

Hyderabad, Apr 18 (UNI) GMR Hyderabad International Airport Ltd (GHIAL) operated Rajiv Gandhi International Airport (RGIA) on Friday announced that it has been awarded the Level 5 Accreditation under the globally recognized Airport Carbon Accreditation (ACA) programme by Airports Council International (ACI).

see more..

Infosys fires 370 trainees despite ongoing govt probe: NITES

18 Apr 2025 | 1:39 PM

Bengaluru, Apr 18 (UNI) The Nascent Information Technology Employees Senate (NITES) has lodged a fresh and strongly-worded complaint with the Ministry of Skill Development and Entrepreneurship, accusing IT giant Infosys Ltd of carrying out the unlawful and unethical termination of 370 apprentices enrolled under the National Apprenticeship Training Scheme (NATS).

see more..
Capital India Finance Limited lists on NSE

Capital India Finance Limited lists on NSE

18 Apr 2025 | 1:08 PM

Mumbai, Apr 18 ( UNI) Capital India Finance Limited, a non-banking financial company, has announced its listing on the National Stock Exchange of India Limited ( NSE).

see more..